Advances in targeting HER2-positive breast cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynaecology
Reference25 articles.
1. Comprehensive overview on state of the art management of early and advanced breast cancer;Harbeck;Lancet,2017
2. HER2-positive breast cancer;Loibl;Lancet,2017
3. ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3);Paluch-Shimon;Breast,2017
4. Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany;Rüschoff;Mod Pathol,2017
5. Comparative Analysis of Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer According to 2007 and 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations;Hanna;J Clin Oncol,2017
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Taste alteration and its relationship with nutritional status among cancer patients receiving chemotherapy, cross-sectional study;PLOS ONE;2024-05-09
2. A historical controlled study of domestic trastuzumab and pertuzumab in combination with docetaxel for the neoadjuvant treatment of early HER2-positive breast cancer;Frontiers in Oncology;2024-02-09
3. Evaluation of chicken chorioallantoic membrane model for tumor imaging and drug development: Promising findings;Animal Models and Experimental Medicine;2024-01-17
4. Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study;Chinese Journal of Cancer Research;2024
5. Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020;Breast Cancer Research and Treatment;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3